Enhancing the QUAlity and Transparency Of health Research
Search for reporting guidelines
Use your browser's Back button to return to your search results
Best Practice in the chemical characterisation of extracts used in pharmacological and toxicological research -The ConPhy MP-Guidelines
| Reporting guideline provided for? (i.e. exactly what the authors state in the paper) |
Reporting the chemical composition of medicinal plant extracts used in pharmacological, toxicological and clinical research studies. |
| Full bibliographic reference | Heinrich M, Jalil B, Abdel-Tawab M, Echeverria J, Kulić Ž, McGaw LJ, Pezzuto JM, Potterat O, Wang JB. Best Practice in the chemical characterisation of extracts used in pharmacological and toxicological research-The ConPhyMP-Guidelines. Front Pharmacol. 2022;13:953205. |
| Language | English |
| PubMed ID | 36176427 |
| Relevant URLs (full-text if available) |
Read the full-text of the ConPhyMP reporting guideline. |
| Reporting guideline acronym | ConPhyMP |
| Study design | Clinical trials, Experimental studies |
| Clinical area | Complementary and alternative medicine, Pharmaceutical medicine, Toxicology |
| Applies to the whole report or to individual sections of the report? | Harms/adverse effects/safety data, Intervention (exposure), Terminology/definitions |
| Additional information | An online fillable open-access ConPhyMP tool is also available via the GA (Society of Medicinal Plants and Natural Products Research) website at https://ga-online.org/best-practice/ |
| Record last updated on | August 16, 2023 |